PESCARMONA, Edoardo
 Distribuzione geografica
Continente #
NA - Nord America 1.777
EU - Europa 457
AS - Asia 304
SA - Sud America 10
AF - Africa 8
Totale 2.556
Nazione #
US - Stati Uniti d'America 1.767
IT - Italia 134
SG - Singapore 116
SE - Svezia 108
IN - India 93
CN - Cina 79
UA - Ucraina 66
FI - Finlandia 48
DE - Germania 24
GB - Regno Unito 15
BE - Belgio 11
AR - Argentina 9
CA - Canada 9
RO - Romania 9
DK - Danimarca 8
IE - Irlanda 8
BG - Bulgaria 7
GR - Grecia 6
TG - Togo 5
FR - Francia 4
ID - Indonesia 4
IR - Iran 3
NL - Olanda 3
VN - Vietnam 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
RU - Federazione Russa 2
EC - Ecuador 1
EE - Estonia 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
PT - Portogallo 1
TH - Thailandia 1
Totale 2.556
Città #
Fairfield 259
Woodbridge 139
Chandler 133
Houston 126
Ashburn 118
Seattle 101
Cambridge 94
Singapore 85
Wilmington 85
Ann Arbor 77
Princeton 61
Rome 52
Beijing 51
Plano 42
Dearborn 36
Lawrence 36
San Paolo di Civitate 34
Boston 30
Jacksonville 30
Des Moines 25
Millbury 22
San Diego 18
Andover 16
Boardman 15
Norwalk 15
Santa Clara 14
New York 13
Brussels 11
Helsinki 10
Federal 9
Falls Church 7
Pune 7
Sofia 7
Bühl 6
Dublin 6
Hefei 5
Lomé 5
Nanjing 5
Toronto 5
Bremen 4
Jakarta 4
Mannheim 4
San Mateo 4
Falkenstein 3
Hanoi 3
Muizenberg 3
Patna 3
Sacramento 3
Baku 2
Hong Kong 2
Indiana 2
Kilburn 2
Los Angeles 2
Milan 2
Montréal 2
Napoli 2
Nettuno 2
Padova 2
Prague 2
Provo 2
Redmond 2
Salerno 2
Shanghai 2
Southend 2
Torino 2
Trumbull 2
Turin 2
Amsterdam 1
Bangkok 1
Bologna 1
Buffalo 1
Chengdu 1
Corridonia 1
Dallas 1
Edinburgh 1
Frontone 1
Fuzhou 1
Grafing 1
Guangzhou 1
Guayaquil 1
Hebei 1
Jinan 1
Kunming 1
Leawood 1
London 1
Manchester 1
Marseille 1
Menlo Park 1
Messina 1
Nanning 1
North York 1
Ottawa 1
Phoenix 1
Prescot 1
San Cesareo 1
San Jose 1
Seversk 1
Shenyang 1
Springfield 1
Stockholm 1
Totale 1.912
Nome #
MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. 108
Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells 90
Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: Immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications 87
B- and T-cell non-Hodgkin's lymphomas with large multilobated cells: morphological, phenotypic and clinical heterogeneity. 75
CODOX-M/IVAC (NCI 89-C-41) for children and adolescents with small non-cleaved and large B-cell lymphomas. A 14 years monocentric experience 73
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: A 15-year monocentric experience. 73
Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: A case series from 2010 to 2014 72
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients 70
pathogenetic and clinical implications of bcl-6 and bcl-2 gene configuration in nodal diffuse large B-cell lymphomas 68
Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas 64
MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis 63
Epigenetic silencing of miR-145-5p contributes to brain metastasis 62
Generation of biologically active retro-genes upon interaction of mouse spermatozoa with exogenous DNA 62
Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: Report of 12 cases from a single institution 62
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 62
Histopathological features and clinical course of the gastrointestinal stromal tumors 62
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden 60
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy 60
Myxoid chondrosarcoma of the mediastinum 57
Neutropenic enterocolitis in patients with acute leukemia: Prognostic significance of bowel wall thickening detected by ultrasonography 57
Regulated expression of MUC1 epithelial antigen in erythropoiesis 57
null 54
Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patients 54
Early autologous stem-cell transplantation versus versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin lymphoma: an Italian multicenter randomized trial 51
Prognostic value of the histologic classification of peripheral T-cell lymphoma: a clinico-pathologic study of 71 HTLV-1 negative cases. 51
Diagnosi differenziale tra linfoadenopatie superficiali benigne e maligne con color power doppler e mezzo di contrasto per ultrasuoni (LEVOVIST). 50
Detection of TT virus in lymph node biopsies of B-CELL lymphoma and Hodgkin's disease, and its association with EBV infection 49
Is bone marrow trephine biopsy always mandatory in staging Hodgkin's disease? 48
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study 48
Isolated granulocytic sarcoma of the skin in an elderly patient: good response to treatment with local radiotherapy and low-dose methotrexate 46
A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma 46
p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome 45
C-kit expression in gastrointestinal stromal tumors (GISTs): possible histogenetic and clinical implications 45
Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments 43
“Composite” lymphoma, lymphoplasmocytoid and diffuse large B-cell lymphoma of the spleen molecular-genetic evidence of a common clonal origin. 42
Espressione del c-kit nei tumori stromali gastrointestinali 41
The role of high resolution pulsed and color doppler ultrasound in the differential diagnosis of benign and malignant lymphadenopaty. 40
Novel biomarkers for thymic carcinoma 36
Systemic lymphadenopathy (LAS) in intraveneous drug abusers. Histology, immunohistochemistry and electron microscopy: pathogenetic correlations 33
Long non-coding RNAs contribution to cell migration and lipid metabolism in thymic epithelial tumor cells 31
NPM1-mutated acute myeloid leukaemia occuring in JAK2-V617F+ primary myelofibrosis: de-novo origin? 30
NODAL PERIPHERAL T -CELL LYMPHOMA ASSOCIATED WITH WARTHIN'S TUMOR 30
Modificazioni morfologiche ed analisi comparativa dei composti fosforilati in NMR 31P in organi destinati al trapianto. 29
Lectin I of ulex europaeus as a marker of a subset of histiocytic tumors of the lympho node 28
Long non-coding RNAs contribution to cell migration and lipid metabolism in Thymic Epithelial Tumor Cells 28
Studio ultrastrutturale della pleura al M.E.S. 27
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients 27
Primary mediastinal large B cell lymphoma with sclerosis: A clinical study of 92 patients treated at a single institution with macop-B and radiotherapy 27
NODAL AND NON-NODAL MANTLE CELL LYMPHOMAS DISPLAY A DIFFERENT GENOMIC PROFILE AND IGHV MUTATIONAL STATUS 25
null 21
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma 20
Thymic carcinomas and thymic neuroendocrine tumors. A tribute to Dr. Juan Rosai 20
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 19
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 16
Totale 2.644
Categoria #
all - tutte 8.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020508 0 0 0 32 54 93 82 70 59 61 41 16
2020/2021182 21 23 10 12 9 12 11 21 16 29 16 2
2021/2022532 3 25 50 20 79 13 12 50 31 54 94 101
2022/2023556 107 100 33 48 69 66 18 38 55 3 15 4
2023/2024221 9 38 9 14 15 32 13 11 4 29 26 21
2024/2025134 15 60 50 9 0 0 0 0 0 0 0 0
Totale 2.644